Sepul Bio reaffirms its dedication to advancing treatments for rare genetic eye diseases such as LCA10 and Usher2a. While clinical trials for these treatments have not yet started, we recommend patients with inherited retinal diseases to maintain regular check-ups with their specialist ophthalmogist. An information will be released once clinical trials begin, ensuring you stay informed about potential participation opportunities. Thank you. Best regards, The Sepul Bio Team.